News SyntheticMR AB

Equities

SYNT

SE0015987946

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-01-30 pm EST			5-day change	1st Jan Change
27.7 ^SEK	+1.09%		-.--%	+4.14%

Apr. 17	SyntheticMR AB and SimonMed Imaging Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from Synthetic Software at SimonMed Facilities	CI
Mar. 27	SyntheticMR Receives FDA 510(k) Clearance for Their Next Generation Solution SyMRI 3D	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Notice to attend the annual general meeting of SyntheticMR AB (publ)	Apr. 19	AQ
SyntheticMR publishes annual report for 2023	Apr. 19	AQ
SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities.	Apr. 17	AQ
SyntheticMR AB and SimonMed Imaging Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from Synthetic Software at SimonMed Facilities	Apr. 17	CI
SyntheticMR : and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities	Apr. 17	PU
SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D	Mar. 27	AQ
SyntheticMR Receives FDA 510(k) Clearance for Their Next Generation Solution SyMRI 3D	Mar. 27	CI
Decided allocation regarding incentive program LTIP 2024 and TO 2	Mar. 12	AQ
Fixed subscription price for warrants of series TO 2 and TO 3	Mar. 05	AQ
Philips teams with Synthetic MR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients at ECR2024	Mar. 01	AQ
Royal Philips Partners SyntheticMR to Roll Out New Brain Disorder Diagnosis Technology	Mar. 01	MT
Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients	Mar. 01	AQ
Subscription price for shares in the incentive program LTIP 2024	Feb. 27	AQ
Report from the extraordinary general meeting in SyntheticMR AB (publ)	Feb. 20	AQ
Year-End report January - December 2023	Feb. 20	AQ
SyntheticMR AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
SyntheticMR AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Notice to attend the extraordinary general meeting of SyntheticMR AB (publ)	Jan. 19	AQ
SyntheticMR AB intends to introduce incentive programs for the company's staff	Jan. 18	AQ
SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking	Dec. 18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SyntheticMR AB

Equities

SYNT

SE0015987946

Summary

Filters